Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Miriam Kim, MD
Leukemia Specialist
St. Louis, MO
Clinical expertise
Acute Myeloid Leukemia
Spoken languages
English
About
Dr. Kim's goal is to develop chimeric antigen receptor T cells as a safe and effective therapy for AML. To this end, I am exploring different target antigens for CAR T cell therapy, investigating mechanisms to enhance the anti-tumor effect of CAR T cells, and finding methods to circumvent the toxicity associated with T cell immunotherapy in the setting of myeloid malignancies.
Care center
Washington University School Of Medicine
660 S Euclid Ave, St. Louis, MO 63110, USA